The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RNA expression-based hypoxia score as a prognostic and predictive biomarker in hepatocellular carcinoma.
 
Ashton Connor
No Relationships to Disclose
 
Harris Benjamin Krause
Employment - Caris Life Sciences
 
Brandee A. Price
Employment - Caris Life Sciences
 
Andrew Elliott
Employment - Caris Life Sciences
 
Moh'd M. Khushman
Stock and Other Ownership Interests - Cardiff Oncology
Consulting or Advisory Role - Cardinal Health; Muerus; TriSalus Life Sciences
Speakers' Bureau - Caris Life Sciences
Research Funding - Abbvie (Inst); FOGPharma (Inst); IgM Biosciences (Inst); Torl Biotherapeutics (Inst)
 
Emil Lou
Honoraria - Boston Scientific; Daiichi Sankyo/UCB Japan (Inst); GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure
Research Funding - Intima; Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Minnetronix Medical; NomoCan
 
Emmanuel S. Antonarakis
Consulting or Advisory Role - AADi; AIkido Pharma; Amgen; AstraZeneca; Bayer (Inst); Blue Earth Diagnostics; Corcept Therapeutics; Curium Pharma; Foundation Medicine; Hookipa Pharma; Janssen Biotech; Lilly; Menarini Silicon Biosystems; Merck; Pfizer; Sanofi; Tango Therapeutics; Tempus; Z-Alpha
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Merck (Inst); Orion Health (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
 
Sanjay Goel
Stock and Other Ownership Interests - Johnson and Johnson; Merck; Moderna Therapeutics
Honoraria - GlaxoSmithKline
Research Funding - Amgen (Inst); BioMed Valley Discoveries (Inst); Deciphera (Inst); Dragonfly Therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Takeda (Inst); Xilio Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364
 
Maen Abdelrahim
No Relationships to Disclose
 
Sudha Kodali
Consulting or Advisory Role - AstraZeneca; Sirtex Medical
 
Ashish Saharia
No Relationships to Disclose
 
Rafik Mark Ghobrial
No Relationships to Disclose
 
George W. Sledge
Employment - Caris Life Sciences
Leadership - Caris Life Sciences; Syndax; Tessa Therapeutics
Stock and Other Ownership Interests - Caris Life Sciences; Pionyr; Syndax
Consulting or Advisory Role - Caris Life Sciences; Syndax
Travel, Accommodations, Expenses - Caris Life Sciences
 
Andrew Barbas
No Relationships to Disclose